Recap: Onconova Therapeutics Q4 Earnings

Onconova Therapeutics ONTX reported its Q4 earnings results on Thursday, March 17, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Onconova Therapeutics beat estimated earnings by 40.74%, reporting an EPS of $-0.16 versus an estimate of $-0.27.

Revenue was down $1.00 thousand from the same period last year.

Last quarter the company beat on EPS by $0.11 which was followed by a 1.72% drop in the share price the next day.

Here's a look at Onconova Therapeutics's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	-0.33	-0.28	-0.45	-0.45
EPS Actual	-0.22	-0.27	-0.30	-0.45
Revenue Estimate	50.00K	20.00K	60.00K	40.00K
Revenue Actual	57.00K	57.00K	56.00K	57.00K

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.